Sagimet Biosciences (SGMT) Equity Average (2023 - 2024)
Sagimet Biosciences has reported Equity Average over the past 2 years, most recently at $177.0 million for Q3 2024.
Sagimet Biosciences has reported Equity Average over the past 2 years, most recently at $177.0 million for Q3 2024.